OSR Health (OSRH) EBITDA Margin (2024 - 2026)
OSR Health's (OSRH) quarterly EBITDA Margin came in at 960.79% in Q2 2026, down 50028.0% year-over-year from N/an in Q2 2025, and down 26.82% quarter-over-quarter from 757.59% in Q1 2026.
Powered by 
Analysis
OSR Health (OSRH) EBITDA Margin (2024 - 2026) Analysis & Trends
OSR Health has disclosed EBITDA Margin across 3 years of filings, most recently posting 960.79% for Q2 2026.
- In Q2 2026, EBITDA Margin fell 50028.0% year-over-year to 960.79%; the TTM figure through Jun 2026 stood at 933.97% (down 56735.0% YoY), while the FY2025 annual figure was 631.15%, down 29996.0% from the prior year.
- EBITDA Margin came in at 960.79% for Q2 2026 at OSR Health, down from 757.59% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 176.24% in Q4 2024 to a low of 1675.86% in Q4 2025.
- Average EBITDA Margin over 3 years is 618.04%, with a median of 446.94% recorded in 2024.
- The largest YoY upside for EBITDA Margin was 2046 bps in 2025 against a maximum downside of 149962 bps in 2025.
- Over 3 years, EBITDA Margin stood at 176.24% in 2024, then tumbled by 851 bps to 1675.86% in 2025, then jumped by 43 bps to 960.79% in 2026.
- Per Business Quant data, the three most recent EBITDA Margin figures were 960.79% in Q2 2026, 757.59% in Q1 2026, and 1675.86% in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 34.95% |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | -133.21% |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 37.40% |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 30.15% |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 32.54% |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | -562.07% |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 17.93% |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | -23.56% |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | -25,380.93% |
| 10 | OSR Health | 6.59 Mn | 4.94 Mn | 86,605.00 | -960.79% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -960.79% |
| Mar 31, 2026 | -757.59% |
| Dec 31, 2025 | -1,675.86% |
| Sep 30, 2025 | -605.89% |
| Jun 30, 2025 | -460.51% |
| Mar 31, 2025 | -383.28% |
| Dec 31, 2024 | -176.24% |
| Sep 30, 2024 | -433.36% |
| Jun 30, 2024 | -364.03% |
| Mar 31, 2024 | -362.83% |